(Q39481130)

12 September 2017

title

Evaluation and management of men whose radical prostatectomies failed: results of an international survey (English)

1 reference

12 September 2017

Ornstein DK

1

1 reference

12 September 2017

Colberg JW

2

1 reference

12 September 2017

Virgo KS

3

1 reference

12 September 2017

Chan D

4

1 reference

12 September 2017

Johnson ET

5

1 reference

12 September 2017

Oh J

6

1 reference

12 September 2017

Johnson FE

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

12 September 2017

1 reference

12 September 2017

volume

52

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

1047-1054

1 reference

Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Early complications of contemporary anatomical radical retropubic prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Results of radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

The Effect of Radiation Therapy after Radical Prostatectomy in Patients with Elevated Prostate Specific Antigen Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Prostate Specific Antigen and Local Recurrence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Retroperitoneal and pelvic lymph node imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: comparison with the clinical and histological staging.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Radiotherapy for isolated increases in serum prostate-specific antigen levels after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Proceedings: The Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2898%2900403-8

7 January 2021

10.1016/S0090-4295(98)00403-8

Identifiers

DOI

1 reference

12 September 2017

1 reference